Richard Alexander Collins - 21 May 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Richard A Collins
Issuer symbol
DXCM
Transactions as of
21 May 2021
Net transactions value
+$0.91
Form type
4
Filing time
25 May 2021, 19:16:15 UTC
Next filing
29 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Other $0 -787 -100% $0.000000* 0 20 May 2021 Direct F1
transaction DXCM Common Stock Award $0.91 +910 $0.001000* 910 21 May 2021 Direct F2, F3
transaction DXCM Common Stock Other $0 +787 +9.9% $0.000000 8,704 20 May 2021 by Trust F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units.
F2 The RSU Award was granted on May 21, 2021 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F3 Represents 910 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting.
F4 Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee.